303 Broadway, Suite 1100,
Cincinnati , OH, 45202-4203

Rank

Rank Universe

Summary

The fund seeks capital appreciation by investing in companies in the United States.

The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in U.S. equity securities.

Then the manager constructs a portfolio of stocks from a l More

Link

Directors

Mar 14, 2024
  • Jill T. McGruder
  • William C. Gale
  • Sally J. Staley
  • Kevin A. Robie
  • Karen Carnahan
  • William H. Zimmer III
  • Susan M. King
  • E. Blake Moore, Jr.

Chief Compliance Officer

  • Timothy S. Stearns

Price

  • $ 9.66 ( +0 )
    Dec 8, 2023
    Last Close
  • Net Assets
  • $15.4M
    Nov 24, 2023
  • Holding
  • 80
    Nov 24, 2023
    More

  • 52-Week High/Low
  • $13.65 - $9.42
  • Turnover
  • 229%
  • Expense Ratio
  • 1.51%

Company Name

Holding

AbbVie Inc. 3.06 %
The Kroger Co. 2.91 %
Merck & Co., Inc 2.89 %
Kellogg Company 2.88 %
Verizon Communications Inc. 2.87 %
Johnson & Johnson 2.81 %
Eli Lilly & Co. 2.8 %
General Mills, Inc. 2.8 %
Pfizer Inc. 2.69 %
Humana Inc. 2.67 %
More 2.67 %

Advisor

Advisor

TOBAM S.A.S.

Tenure

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

-31.73%

5 Year

-32.87%

Best

19.01%

2013

Worst

-33.91%

2008

Alpha

TDEAX S&P 500

Chart +